Robbins Delira, Zhao Yunfeng
Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
J Signal Transduct. 2012;2012:101465. doi: 10.1155/2012/101465. Epub 2011 Oct 5.
The formation of reactive oxygen species (ROS) is a result of incomplete reduction of molecular oxygen during cellular metabolism. Although ROS has been shown to act as signaling molecules, it is known that these reactive molecules can act as prooxidants causing damage to DNA, proteins, and lipids, which over time can lead to disease propagation and ultimately cell death. Thus, restoring the protective antioxidant capacity of the cell has become an important target in therapeutic intervention. In addition, a clearer understanding of the disease stage and molecular events that contribute to ROS generation during tumor promotion can lead to novel approaches to enhance target specificity in cancer progression. This paper will focus on not only the traditional routes of ROS generation, but also on new mechanisms via the tumor suppressor p53 and the interaction between p53 and MnSOD, the primary antioxidant enzyme in mitochondria. In addition, the potential consequences of the p53-MnSOD interaction have also been discussed. Lastly, we have highlighted clinical implications of targeting the p53-MnSOD interaction and discussed recent therapeutic mechanisms utilized to modulate both p53 and MnSOD as a method of tumor suppression.
活性氧(ROS)的形成是细胞代谢过程中分子氧不完全还原的结果。尽管ROS已被证明可作为信号分子,但众所周知,这些活性分子可作为促氧化剂,对DNA、蛋白质和脂质造成损害,随着时间的推移,可能导致疾病传播并最终导致细胞死亡。因此,恢复细胞的保护性抗氧化能力已成为治疗干预的重要目标。此外,更清楚地了解疾病阶段以及在肿瘤促进过程中导致ROS产生的分子事件,可能会带来增强癌症进展中靶标特异性的新方法。本文不仅将关注ROS产生的传统途径,还将关注通过肿瘤抑制因子p53以及p53与线粒体中的主要抗氧化酶MnSOD之间的相互作用产生ROS的新机制。此外,还讨论了p53-MnSOD相互作用的潜在后果。最后,我们强调了靶向p53-MnSOD相互作用的临床意义,并讨论了最近用于调节p53和MnSOD作为肿瘤抑制方法的治疗机制。